nodes	percent_of_prediction	percent_of_DWPC	metapath
Gadopentetate dimeglumine—PGD—uterine cervix—vaginal cancer	0.151	0.151	CbGeAlD
Gadopentetate dimeglumine—PGD—urethra—vaginal cancer	0.138	0.138	CbGeAlD
Gadopentetate dimeglumine—PGD—endometrium—vaginal cancer	0.136	0.136	CbGeAlD
Gadopentetate dimeglumine—PGD—mammalian vulva—vaginal cancer	0.132	0.132	CbGeAlD
Gadopentetate dimeglumine—PGD—uterus—vaginal cancer	0.126	0.126	CbGeAlD
Gadopentetate dimeglumine—PGD—female reproductive system—vaginal cancer	0.113	0.113	CbGeAlD
Gadopentetate dimeglumine—PGD—female gonad—vaginal cancer	0.103	0.103	CbGeAlD
Gadopentetate dimeglumine—PGD—vagina—vaginal cancer	0.102	0.102	CbGeAlD
